You are here

  • Home
  • Archive
  • Volume 15, Issue 3
  • Vitamin E increases prostate cancer risk in middle-aged men relative to placebo: no significant association observed with selenium, either alone or in combination with vitamin E

Article Text

Article menu
Download PDFPDF
Primary health care
Randomised controlled trial
Vitamin E increases prostate cancer risk in middle-aged men relative to placebo: no significant association observed with selenium, either alone or in combination with vitamin E
  1. Gwen Wyatt
  1. College of Nursing, Michigan State University, East Lansing, Michigan, USA
  1. Correspondence to Gwen Wyatt
    College of Nursing, Michigan State University, 515 W Fee Hall, East Lansing, MI 48824, USA; gwen.wyatt{at}hc.msu.edu

https://doi.org/10.1136/ebnurs-2012-100551

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Klein EA, Thompson IM Jr., Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011;306:1549–56.OpenUrlCrossRefPubMedWeb of Science

    Implications for practice and research

    • ■ Clinicians should inform patients that vitamin E significantly increased the risk of prostate cancer among healthy men, and should be avoided.

    • ■ Extended follow-up of common doses of vitamins and supplements may reveal new and critically significant findings.

    Context

    The lifetime risk for prostate cancer in the USA is currently estimated to be 16%. The objective of this study was to determine the long-term effect of vitamin E and selenium on the risk of prostate cancer in healthy men who had participated in the …

    View Full Text

    Footnotes

    • Competing interests None.